Catalent (CTLT) is a health products and solutions provider headquartered in Somerset, New Jersey. Operating through business units in Asia Pacific, Europe, Latin America and North America, Catalent reaches out to more than 100 markets. The company holds over 1,200 patents and specialises in biologics, pre-formulation and formulation, has its own optoform technology and delivers a range of pharmaceutical services. Catalent is featured in Top 50 Pharma List and ranks 41th in Top 50 biotech companies list. Catalent shares are traded on the New York Stock Exchange (NYSE).